Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence

Journal of the American Osteopathic Association

Volumn 109, Issue 6 SUPPL. 2, 2009, Pages

  Oxman, Michael N ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VARICELLA ZOSTER VACCINE;

CELLULAR IMMUNITY; CLINICAL FEATURE; CONFERENCE PAPER; ENZYME LINKED IMMUNOSPOT ASSAY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HERPES ZOSTER; PATHOGENESIS; POSTHERPETIC NEURALGIA; SENSORY GANGLION; VARICELLA ZOSTER VIRUS;

AGE FACTORS; CELL AGING; HERPES ZOSTER; HUMANS; IMMUNITY, CELLULAR; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 67650475990     PISSN: 00986151     EISSN: 00986151     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9-20. Available at: http://www.pub medcentral.nih.gov/picrender.fcgi?artid=1898279&b lobtype=pdf. Accessed April 8, 2009.
2. Head H, Campbell AW. The pathology of herpes zoster and its bearing on sensory localisation. Brain. 1900;23:353-523.
3. Gnann JW Jr, Whitley RJ. Herpes zoster [review]. N Engl J Med. 2002;347:340-346.
4. Weller TH. Varicella and herpes zoster: a perspective and overview. J Infect Dis. 1992;166(suppl 1):S1-S6.
5. Preblud SR, Orenstein WA, Bart KJ. Varicella: clinical manifestations, epidemiology and health impact in children. Pediatr Infect Dis. 1984;3:505-509. (Pubitemid 15220591)
6. Levin MJ, Oxman MN, Zhang JH, Johnson GR, Stanley H, Hayward AR, et al; Veterans Affairs Cooperative Studies Program Shingles Prevention Study Investigators. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis. 2008;197:825-835.
7. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al ; Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271-2284. Available at: http://content.nejm.org/cgi/content/full/352/22/2271. Accessed April 8, 2009.
8. Oxman MN. Clinical manifestations of herpes zoster. In: Arvin AM, Gershon AA, eds. Varicella- Zoster Virus: Virology and Clinical Management. Cambridge, England: Cambridge University Press; 2000: 246-275.
9. Cohen JI, Straus SE, Arvin AM. Varicella-zoster virus replication, pathogenesis and management. In: Knipe DM, Howley PM, eds. Fields Virology. 5th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2007:2773-2818.
10. Oxman MN. Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology. 1995;45(12 suppl 8):S41-S46. (Pubitemid 26163686)
11. Hope-Simpson RE. Postherpetic neuralgia. J R Coll Gen Pract. 1975;25:571-575.
12. Kost RG, Straus SE. Postherpetic neuralgia- pathogenesis, treatment, and prevention. N Engl J Med. 1996;335:32-42. (Pubitemid 26230812)
13. Dworkin RH, Gnann JW Jr, Oaklander AL, Raja SN, Schmader KE, Whitley RJ. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain. 2008;9(1 suppl 1):S37-S44. (Pubitemid 350309525)
14. Watson CP, Deck JH, Morshead C, Van der Kooy D, Evans RJ. Post-herpetic neuralgia: further postmortem studies of cases with and without pain. Pain. 1991;44:105-117.
15. Watson CP, Oaklander AL. Postherpetic neuralgia. Pain Pract. 2002;2:295-307.
16. Stanberry LR, Oxman MN, Simmons A. Herpes simplex viruses. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious Diseases. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2004:1905-1917. (Pubitemid 39145462)
17. Straus SE, Schmader KE, Oxman MN. Varicella and herpes zoster. In: Fitzpatrick TB; Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, eds. Fitzpatrick's Dermatology in General Medicine. 6th ed. New York, NY: McGraw-Hill Book Company; 2003:2070-2085.
18. Ross AH. Modification of chickenpox in family contacts by administration of gamma globulin. N Engl J Med. 1962;267:369-376.
19. Gelb LD. Reducing the incidence and severity of herpes zoster and PHN with zoster vaccination. J Am Osteopath Assoc. 2009;109(suppl 2):S18-S21.
20. Weinberg A, Zhang JH, Oxman MN, Johnson GR, Hayward AR, Caulfield MJ; the VA Cooperative Studies Program Shingles Prevention Study Investigators. VZV-specific immune responses after herpes zoster (HZ) or HZ vaccine and their association with severity of HZ. Poster presented at: 48th Annual ICAAC/IDSA 46th Annual Meeting; October 25-28, 2008; Washington, DC.